Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-11-30FDA Approved: GLIMEPIRIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Glimepiride from Dr. Reddy's Laboratories Limited under an existing ANDA.
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: Effects of EPA and Vitamin E on Leptin, Adiponectin and Enzymatic Antioxidants in Type 2 DM [Phase 4]
This Phase 4 clinical trial update reports results on the effects of EPA and vitamin E on leptin, adiponectin, and enzymatic antioxidants in…
-
CLINICAL_TRIALS trial_result · 2009-11-13Clinical Trial Update: RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes [Phase 3]
Phase 3 RECORD trial evaluating rosiglitazone for cardiac outcomes and glycemic control in type 2 diabetes; the study status is completed wi…
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: Cholesterol Metabolism and Lipid Transfer in Diabetes
Completed clinical trial investigating cholesterol metabolism and lipid transfer in individuals with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: Electronic Feedback on Diabetic Care to General Practitioners [NA]
A completed clinical trial from the University of Aarhus evaluated the impact of electronic feedback on diabetic care practices by general p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus [Phase 2]
Pfizer conducted a four-year extension to assess the long-term safety of inhaled insulin in adults with Type 1 or Type 2 diabetes; the Phase…
-
CLINICAL_TRIALS trial_result · 2009-11-05Clinical Trial Update: Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes [Phase 4]
Phase 4 trial comparing rosiglitazone–metformin versus metformin–sulfonylurea examined beta-cell function in Type 2 Diabetes Mellitus; resul…
-
CLINICAL_TRIALS trial_result · 2009-11-04Clinical Trial Update: Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) [Phase 3]
A Phase 3 clinical trial comparing two basal insulins in adults with Type 2 diabetes completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-11-04Clinical Trial Update: Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes [Phase 4]
A Phase 4 trial evaluating the effect of adding ezetimibe to statin therapy on postprandial lipemia in people with type 2 diabetes has compl…
-
CLINICAL_TRIALS trial_result · 2009-11-03Clinical Trial Update: To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients [Phase 1]
A Phase 1 study by AstraZeneca evaluated the safety, tolerability, PK and PD of AZD1656 in Japanese patients with Type 2 diabetes mellitus; …
-
CLINICAL_TRIALS trial_result · 2009-11-03Clinical Trial Update: Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE) [Phase 3]
A Phase 3 trial comparing two basal insulin formulations in adults with type 2 diabetes on anti-hyperglycemic medications; results have been…
-
CLINICAL_TRIALS trial_result · 2009-11-03Clinical Trial Update: Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity [Phase 2]
A Phase 2 clinical trial is evaluating vitamin D supplementation in adults with type 2 diabetes and vitamin D deficiency to assess potential…
-
CLINICAL_TRIALS trial_result · 2009-11-03Clinical Trial Update: Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
A completed clinical trial from AstraZeneca assessed the impact of patient education on cardiovascular risk factors in individuals with type…
-
FDA approval · 2009-10-30FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS research · 2009-10-30Clinical Trial Update: Effects of Low Versus High Carbohydrate Diet During Rehabilitation on Cardiovascular Function and Metabolism in Type 2 Diabetes [NA]
An ongoing clinical trial comparing low- versus high-carbohydrate diets during rehabilitation in adults with Type 2 Diabetes Mellitus who ar…
-
CLINICAL_TRIALS trial_result · 2009-10-29Clinical Trial Update: Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress [Phase 4]
This Phase 4 clinical trial update examines the effect of a DPP-4 inhibitor combined with a sulfonylurea on glucose variability and oxidativ…
-
CLINICAL_TRIALS trial_result · 2009-10-23Clinical Trial Update: Sitagliptin Added-on to Insulin Study (0431-051) [Phase 3]
A Phase 3 study evaluating sitagliptin added to insulin in Type 2 diabetes completed with results posted in 2009.
-
FDA approval · 2009-10-21FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOPLUS MET (pioglitazone and metformin hydrochloride) to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2009-10-21Clinical Trial Update: A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus® [Phase 4]
Phase 4 clinical trial comparing the efficacy and safety of Exubera and Lantus in adults with Type 2 diabetes has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2009-10-20Clinical Trial Update: Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes
A clinical trial quantified the incretin effect in healthy subjects and patients with Type 2 Diabetes. The study has completed and the resul…
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial comparing Technosphere insulin inhalation powder (Afrezza) to rapid-acting insulin in adults with Type 2 diabetes mellitus h…
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus. [Phase 2]
A Phase 2 clinical trial comparing inhaled insulin to subcutaneous insulin in adults with Type 2 diabetes mellitus has been completed.
-
CLINICAL_TRIALS research · 2009-10-08Clinical Trial Update: Diabetes Prevention In Estrie [NA]
A completed clinical trial conducted by Université de Sherbrooke on preventing diabetes in overweight individuals with glucose intolerance i…
-
CLINICAL_TRIALS trial_result · 2009-10-07Clinical Trial Update: Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes [Phase 4]
A Phase 4 trial assesses adding pioglitazone to existing therapy versus placebo in Type 2 diabetes, evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2009-10-06Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-38431055 in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of JNJ-38431055 in healthy male volunteers; the trial …